Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
Clinical trial NCT06150716 · RECRUITING
Trial details
- NCT number
- NCT06150716
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2028-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.